Telepatia, a healthcare AI company based in São Paulo, has raised $33 million in Series A funding to accelerate the expansion of its AI-powered platform across Latin America. The round was led by Andreessen Horowitz, with participation from prominent technology leaders and entrepreneurs. The funding follows a seed round raised last year and reflects growing investor interest in healthcare AI solutions tailored to the needs of emerging markets and regional healthcare systems.
The company provides an AI platform designed specifically for healthcare organizations, offering tools that support clinical documentation, decision support and administrative workflows. In addition to these capabilities, Telepatia has developed a suite of AI-powered healthcare assistants, including virtual doctors, nurses and auditors. The platform is trained on peer-reviewed medical literature, clinical guidelines and local healthcare protocols, allowing it to align recommendations and workflows with regional standards of care across Latin America.
Since its launch, Telepatia has expanded into dozens of hospital systems and reached millions of patients across the region. The company reports improvements in clinical protocol adherence and reductions in medical errors through real-time AI support. The new funding will be used to further develop its AI workforce capabilities, expand deployments and strengthen its presence across Latin American healthcare markets. More broadly, the investment highlights accelerating momentum behind healthcare AI initiatives in the region, where governments, providers and technology companies are increasingly exploring AI to improve efficiency, care quality and healthcare access.
Click here to read the original news story.
